Search Results 101-110 of 17572 for tsh

  1. Thyroid eye disease clinic — The Mayo Clinic Model

    Patients have orthoptics, thyroid function tests, a TSH receptor antibody test and an orbital CT prescheduled for the same day. The latter is set for the ...

  2. Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery - Mayo Clinic

    Thyroid stimulating hormone (TSH) 0.3-2.0 mIU/L; Patient is scheduled or being considered for surgical resection of the nodule; I-123 planar and Single Photon ...

  3. Supraventricular tachycardia - Symptoms and causes - Mayo Clinic

    SVT is a heart rhythm disorder that causes a very fast or erratic heartbeat. The heart may beat more than 150 times a minute. Know the symptoms and when ...

  4. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Thyroid-stimulating hormone (TSH) within normal limits (WNL); supplementation is acceptable to achieve a TSH WNL; No clinical or radiographic evidence of ...

  5. Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair - Mayo Clinic

    Thyroid-stimulating hormone (TSH) within normal limits (WNL); supplementation is acceptable to achieve a TSH WNL; in patients with abnormal TSH, if free T4 ...

  6. Thyroid Eye Disease Research Program

    Contact the Thyroid Eye Disease Research Program at Mayo Clinic with questions about its research on thyroid-stimulating hormone receptor (TSHr) antibodies ...

  7. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    Thyroid stimulating hormone (TSH) within normal limits (WNL); medications for thyroid dysfunction are allowed as long as TSH is normal at registration; in ...

  8. Thyroid Eye Disease Research Program

    Contact the Thyroid Eye Disease Research Program at Mayo Clinic with questions about its research on thyroid-stimulating hormone receptor (TSHr) antibodies ...

  9. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

    Have confirmed locally advanced or metastatic NSCLC · Thyroid-stimulating hormone (TSH) within normal limits · Have measurable disease per Response Evaluation ...

  10. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    Secondary hypothyroidism or inadequately controlled primary hypothyroidism (thyroid stimulating hormone \[TSH\] value outside the normal range at screening as ...